FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Share Price

Certificat

DE000JK78D43

Delayed Börse Stuttgart 20:58:55 26/06/2024 BST
1.92 EUR +12.28% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-95.12%
1 month-93.42%
Date Price Change
26/06/24 1.92 +12.28%
25/06/24 1.71 -58.19%
24/06/24 4.09 +2.00%
21/06/24 4.01 +1.26%
20/06/24 3.96 -9.17%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 08:58 pm

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK78D4
ISINDE000JK78D43
Date issued 06/05/2024
Strike 35.57 $
Maturity Unlimited
Parity 2.84 : 1
Emission price 10.13
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 39.56
Lowest since issue 1.67
Spread 0.3
Spread %13.70%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.64 USD
Average target price
49.93 USD
Spread / Average Target
+22.87%
Consensus